Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Alemtuzumab induction in pediatric kidney transplantation.

Nguyen C, Shapiro R.

Pediatr Transplant. 2013 Jun;17(4):319-20. doi: 10.1111/petr.12089. Epub 2013 Apr 14. No abstract available.

PMID:
23581963
2.

Alemtuzumab induction in pediatric kidney transplantation.

Kaabak MM, Babenko NN, Samsonov DV, Sandrikov VA, Maschan AA, Zokoev AK.

Pediatr Transplant. 2013 Mar;17(2):168-78. doi: 10.1111/petr.12048.

3.

Postoperative cardiac tamponade after kidney transplantation: a possible consequence of alemtuzumab-induced cytokine release syndrome.

Adams PS, Shapiro R, Hilmi IA.

Transplantation. 2013 Feb 15;95(3):e18-9. doi: 10.1097/TP.0b013e31827d9757. Review. No abstract available.

PMID:
23380870
4.

Re: letter to the editor on "Alemtuzumab induction in renal transplantation: a meta-analysis and systemic review".

Zhang X, Wang L.

Transpl Immunol. 2013 Mar;28(2-3):72. doi: 10.1016/j.trim.2013.01.002. Epub 2013 Jan 23. No abstract available.

PMID:
23352934
5.

Alemtuzumab induction therapy in kidney transplantation.

Dhaun N, Kluth DC.

Lancet. 2015 Feb 28;385(9970):770. doi: 10.1016/S0140-6736(15)60430-5. No abstract available.

PMID:
25752171
6.

Alemtuzumab induction therapy in kidney transplantation.

Berghofen A, Singer T, Krüger B, Krämer BK, Benck U.

Lancet. 2015 Feb 28;385(9970):770-1. doi: 10.1016/S0140-6736(15)60431-7. No abstract available.

PMID:
25752170
7.

Alemtuzumab induction therapy in kidney transplantation.

Kuypers DR.

Lancet. 2014 Nov 8;384(9955):1649-51. doi: 10.1016/S0140-6736(14)61174-0. Epub 2014 Jul 28. No abstract available.

PMID:
25078307
8.

Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation.

Shapiro R, Ellis D, Tan HP, Moritz ML, Basu A, Vats AN, Kayler LK, Erkan E, McFeaters CG, James G, Grosso MJ, Zeevi A, Gray EA, Marcos A, Starzl TE.

Am J Transplant. 2007 Dec;7(12):2736-8. Epub 2007 Oct 1.

9.

Alemtuzumab induction therapy in kidney transplantation - Authors' reply.

Haynes R, Baigent C, Landray MJ, Harden P, Friend P.

Lancet. 2015 Feb 28;385(9970):771. doi: 10.1016/S0140-6736(15)60432-9. No abstract available.

PMID:
25752173
10.

Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.

Morgan RD, O'Callaghan JM, Knight SR, Morris PJ.

Transplantation. 2012 Jun 27;93(12):1179-88. doi: 10.1097/TP.0b013e318257ad41. Review.

PMID:
22660659
11.

Systematic reviews of alemtuzumab in renal transplantation.

O'Callaghan JM, Morgan RD, Knight SR, Morris PJ.

Transpl Immunol. 2013 Mar;28(2-3):71. doi: 10.1016/j.trim.2013.01.004. Epub 2013 Jan 23. No abstract available.

PMID:
23352935
12.

Transplantation: Alemtuzumab induction reduces acute rejection risk.

Sidaway P.

Nat Rev Nephrol. 2014 Oct;10(10):542. doi: 10.1038/nrneph.2014.143. Epub 2014 Aug 12. No abstract available.

PMID:
25112441
13.

Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant.

Refaie AF, Mahmoud KM, Ismail AM, Sheashaa HA, Kamal AI, Ghoneim MA.

Exp Clin Transplant. 2011 Oct;9(5):295-301.

14.

Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up.

Tan HP, Donaldson J, Basu A, Unruh M, Randhawa P, Sharma V, Morgan C, McCauley J, Wu C, Shah N, Zeevi A, Shapiro R.

Am J Transplant. 2009 Feb;9(2):355-66. doi: 10.1111/j.1600-6143.2008.02492.x. Epub 2008 Dec 15.

15.

Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death.

Plata-Munoz JJ, Vaidya A, Fuggle SV, Friend PJ.

Transpl Int. 2009 Oct;22(10):1024-7. doi: 10.1111/j.1432-2277.2009.00910.x. Epub 2009 Jul 13. No abstract available.

16.

The search for the optimal antibody induction strategy in kidney transplantation: still "hazy" after all these years.

Stratta RJ.

Clin Transplant. 2015 Jul;29(7):569-72. doi: 10.1111/ctr.12543. Epub 2015 Apr 16. No abstract available.

PMID:
25880305
17.

Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor kidney transplantation.

Sampaio MS, Kadiyala A, Gill J, Bunnapradist S.

Transplantation. 2009 Oct 15;88(7):904-10. doi: 10.1097/TP.0b013e3181b724a5.

PMID:
19935462
18.

[HLA-incompatibility and kidney transplant: a question of desensitization].

Grosjean F.

G Ital Nefrol. 2011 Nov-Dec;28(6):581. Italian. No abstract available.

PMID:
22167608
19.

Alemtuzumab induction in deceased donor kidney transplantation.

Shin M, Song SH, Kim JM, Kwon CH, Joh JW, Lee SK, Kim SJ.

Transplant Proc. 2011 Jul-Aug;43(6):2365-78. doi: 10.1016/j.transproceed.2011.05.032.

PMID:
21839271
20.

Campath induction for kidney transplantation: report of 297 cases.

Ortiz J, Palma-Vargas J, Wright F, Bingaman A, Agha I, Rosenblatt S, Foster P.

Transplantation. 2008 Jun 15;85(11):1550-6. doi: 10.1097/TP.0b013e31816f60cf.

PMID:
18551058
Items per page

Supplemental Content

Write to the Help Desk